105 related articles for article (PubMed ID: 8305515)
1. Preparation and characterization of conjugates of monoclonal antibodies and staphylococcal enterotoxin A using a new hydrophilic cross-linker.
Akerblom E; Dohlsten M; Brynö C; Mastej M; Steringer I; Hedlund G; Lando P; Kalland T
Bioconjug Chem; 1993; 4(6):455-66. PubMed ID: 8305515
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents.
Dohlsten M; Hedlund G; Akerblom E; Lando PA; Kalland T
Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9287-91. PubMed ID: 1924393
[TBL] [Abstract][Full Text] [Related]
3. Superantigen-induced cytokines suppress growth of human colon-carcinoma cells.
Dohlsten M; Sundstedt A; Björklund M; Hedlund G; Kalland T
Int J Cancer; 1993 May; 54(3):482-8. PubMed ID: 8509223
[TBL] [Abstract][Full Text] [Related]
4. Antibody-targeted superantigens induce lysis of major histocompatibility complex class II-negative T-cell leukemia lines.
Ihle J; Holzer U; Krull F; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
Cancer Res; 1995 Feb; 55(3):623-8. PubMed ID: 7530598
[TBL] [Abstract][Full Text] [Related]
5. T cell killing of human colon carcinomas by monoclonal-antibody-targeted superantigens.
Lando PA; Dohlsten M; Hedlund G; Akerblom E; Kalland T
Cancer Immunol Immunother; 1993; 36(4):223-8. PubMed ID: 8439985
[TBL] [Abstract][Full Text] [Related]
6. (6-Maleimidocaproyl)hydrazone of doxorubicin--a new derivative for the preparation of immunoconjugates of doxorubicin.
Willner D; Trail PA; Hofstead SJ; King HD; Lasch SJ; Braslawsky GR; Greenfield RS; Kaneko T; Firestone RA
Bioconjug Chem; 1993; 4(6):521-7. PubMed ID: 7508268
[TBL] [Abstract][Full Text] [Related]
7. Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal antibody-phthalocyanine conjugates.
Carcenac M; Larroque C; Langlois R; van Lier JE; Artus JC; Pèlegrin A
Photochem Photobiol; 1999 Dec; 70(6):930-6. PubMed ID: 10628305
[TBL] [Abstract][Full Text] [Related]
8. Construction of an immunotoxin with the pore forming protein StI and ior C5, a monoclonal antibody against a colon cancer cell line.
Tejuca M; Díaz I; Figueredo R; Roque L; Pazos F; Martínez D; Iznaga-Escobar N; Pérez R; Alvarez C; Lanio ME
Int Immunopharmacol; 2004 Jun; 4(6):731-44. PubMed ID: 15135315
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy.
Dohlsten M; Abrahmsén L; Björk P; Lando PA; Hedlund G; Forsberg G; Brodin T; Gascoigne NR; Förberg C; Lind P
Proc Natl Acad Sci U S A; 1994 Sep; 91(19):8945-9. PubMed ID: 8090750
[TBL] [Abstract][Full Text] [Related]
10. Targeting of superantigens.
Kalland T; Dohlsten M; Abrahmsén L; Hedlund G; Björk P; Lando PA; Sundstedt A; Akerblom E; Lind P
Cell Biophys; 1993; 22(1-3):147-64. PubMed ID: 7889537
[TBL] [Abstract][Full Text] [Related]
11. Role of the adhesion molecule ICAM-1 (CD54) in staphylococcal enterotoxin-mediated cytotoxicity.
Dohlsten M; Hedlund G; Lando PA; Trowsdale J; Altmann D; Patarroyo M; Fischer H; Kalland T
Eur J Immunol; 1991 Jan; 21(1):131-5. PubMed ID: 1671356
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody 44-3A6 doxorubicin immunoconjugates: comparative in vitro anti-tumor efficacy of different conjugation methods.
Sinkule JA; Rosen ST; Radosevich JA
Tumour Biol; 1991; 12(4):198-206. PubMed ID: 1651554
[TBL] [Abstract][Full Text] [Related]
13. Structural features of the antibody-A chain linkage that influence the activity and stability of ricin A chain immunotoxins.
Cumber AJ; Westwood JH; Henry RV; Parnell GD; Coles BF; Wawrzynczak EJ
Bioconjug Chem; 1992; 3(5):397-401. PubMed ID: 1329989
[TBL] [Abstract][Full Text] [Related]
14. Enhanced tumor cell selectivity of adriamycin-monoclonal antibody conjugate via a poly(ethylene glycol)-based cleavable linker.
Suzawa T; Nagamura S; Saito H; Ohta S; Hanai N; Kanazawa J; Okabe M; Yamasaki M
J Control Release; 2002 Feb; 79(1-3):229-42. PubMed ID: 11853934
[TBL] [Abstract][Full Text] [Related]
15. Role of cross-linking agents in determining the biochemical and pharmacokinetic properties of Mgr6-clavin immunotoxins.
Dosio F; Arpicco S; Adobati E; Canevari S; Brusa P; De Santis R; Parente D; Pignanelli P; Negri DR; Colnaghi MI; Cattel L
Bioconjug Chem; 1998; 9(3):372-81. PubMed ID: 9576812
[TBL] [Abstract][Full Text] [Related]
16. Binding of staphylococcal enterotoxin A to HLA-DR on B cell lines.
Fischer H; Dohlsten M; Lindvall M; Sjögren HO; Carlsson R
J Immunol; 1989 May; 142(9):3151-7. PubMed ID: 2785135
[TBL] [Abstract][Full Text] [Related]
17. Preparation and in vitro cytotoxicity of a methotrexate-anti-MM46 monoclonal antibody conjugate via an oligopeptide spacer.
Umemoto N; Kato Y; Endo N; Takeda Y; Hara T
Int J Cancer; 1989 Apr; 43(4):677-84. PubMed ID: 2784785
[TBL] [Abstract][Full Text] [Related]
18. A new screening model for safety evaluation of superantigen-antibody recombinant fusion proteins (mAb Fab-SEA/E) using telemetric monitoring in conscious rabbits.
Ilbäck NG; Persson R; Gunnarsson K; Stålhandske T
J Pharmacol Toxicol Methods; 2002; 48(1):31-9. PubMed ID: 12750039
[TBL] [Abstract][Full Text] [Related]
19. Antibodies are capable of directing superantigen-mediated T cell killing of chronic B lymphocytic leukemia cells.
Gidlöf C; Dohlsten M; Kalland T; Tötterman TH
Leukemia; 1995 Sep; 9(9):1534-42. PubMed ID: 7544852
[TBL] [Abstract][Full Text] [Related]
20. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
Chari RV
Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
